Raffin Thomas A.
- SEC CIK
- 0001512119
No open-market purchases or sales filed in the past year.
Current role at each company
- AKYA Akoya Biosciences, Inc.Directoras of Jul 10, 2025
- LUMO Lumos Pharma, Inc.Directoras of Dec 13, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Raffin Thomas A. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AKYA Akoya Biosciences, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 12, 2023 (view filing) | Jun 12 | Same day | Raffin Thomas A.Director | PPurchase | +2.02M | $5.00 | +$10.1M | +14.5%15.9M after | 3 lots |
LUMO Lumos Pharma, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 26, 2022 (view filing) | Aug 25 | 1 day | Raffin Thomas A.Director | PPurchase | +1.15K | $8.46 | +$9.73K | +13.9%9.41K after |